Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence
Mesenchymal stem cells form a population of self-renewing, multipotent cells that can be isolated from several tissues. Multiple preclinical studies have demonstrated that the administration of exogenous MSC could prevent renal injury and could promote renal recovery through a series of complex mech...
Main Authors: | Anna Julie Peired, Alessandro Sisti, Paola Romagnani |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/4798639 |
Similar Items
-
Renal Cancer Stem Cells: Characterization and Targeted Therapies
by: Anna Julie Peired, et al.
Published: (2016-01-01) -
Sex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence
by: Anna Julie Peired, et al.
Published: (2021-09-01) -
Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases
by: Yuling Huang, et al.
Published: (2021-03-01) -
Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants
by: Shujun Lin, et al.
Published: (2020-01-01) -
Use of mesenchymal stem cells for chronic kidney disease
by: Byung Ha Chung
Published: (2019-06-01)